Where I see patients (1)
My reviews
Selected research
- 
							Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma.
							bioRxiv : the preprint server for biology
 - 
							Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy.
							Blood
 - 
							Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
							Expert opinion on investigational drugs
 
					
				
														
														
														
														
														
				
					
				
4.9